The effect produced by the nitric oxide donor SIN-1 on monosynaptic re¯exes was examined. Experiments were performed on anesthetised, paralyzed and spinalized cats. Lumbar monosynaptic re¯exes were produced by stimulation of Ia afferents. I.v. application of SIN-1 (500 ìg/kg) produced a mean marked potentiation of 704% of pre-drug control (100%) in the amplitude of monosynaptic re¯exes. In addition, in other experiments a concentration-dependent effect on the amplitude of monosynaptic re¯exes was observed after microinjections of SIN-1 into the ventral horn (1 ìl; 10 À12 ±10 À3 M), with a mean facilitatory effect of 355%. In both cases, the potentiation was reversible 45 min after i.v. or local application of SIN-1. These results provide the ®rst evidence that monosynaptic re¯exes can be potentiated by nitric oxide. NeuroReport 12:1±5
INTRODUCTION
Nitric oxide (NO) has been shown to be an intercellular signalling molecule, which is freely permeable through the cell membrane, and can be synthesized by neuronal nitric oxide synthase (NOS) [1±3] . There is evidence that NO can be produced in the spinal cord by neuronal NOS localized in motoneurons [4±6] . In this regard, the recent use of histochemistry and neuronal NOS immunocytochemistry, combined with a radioassay detection of catalytic NOS activity, allowed detection in the ventral horn of a very high catalytic NOS activity [7] , suggesting that NOScontaining neurons are localized in this region. In agreement with this suggestion, a previous study [4] showed that $60% of motoneurons are NOS immunoreactive in the major sacral motor nuclei of the cat. These results strengthen the idea that NO released from motoneurons plays a role in synaptic plasticity of the monosynaptic re¯ex pathway.
There have been no experimental studies concerning the action of NO on the monosynaptic re¯ex pathway. The few studies available deal with the action of NO on nociceptive spinal re¯ex activity measured in vitro [8±10] . In order to provide evidence of the effects of NO on the synaptic transmission from Ia afferents to motoneurons, we examined the effects produced by i.v. and local application (into the ventral horn) of 3-morpholinosydnonimine hydrochloride (SIN-1) on monosynaptic re¯exes (MSRs) produced by activation of group Ia afferents. Some results from this study were published previously in abstract form [11] .
MATERIALS AND METHODS
Surgery and anesthesia: Guidelines contained in NIH publication 80-23 revised in 1978 on the principles of laboratory animal care were followed throughout. Experiments were carried out on adult cats (2.5±3.5 kg body weight) initially anesthetized with pentobarbital sodium (Smith Kline, 35-40 mg/kg, i.p.). The lumbo-sacral and low thoracic spinal segments were exposed and the left L5 to S1 ventral roots sectioned. The posterior biceps and semitendinosus (PBSt), and gastrocnemius-soleus (GS) nerves were dissected, sectioned, and their central ends prepared for stimulation [12] .
The mean blood pressure (BP) was monitored through the carotid artery. The left radial vein was also cannulated to administer additional doses (10 mg/kg) of pentobarbital to maintain the animals in deep anaesthesia. After the surgical procedures, the animals were paralysed with a single dose of pancuronium bromide (Pavulon, Organon; 0.3 mg/kg, i.v.) and maintained under arti®cial respiration. Additional doses of pancuronium bromide (0.1 mg/kg, i.v.) were given to maintain paralysis. In addition, the animals were spinalized at the T12 segment. Adequacy of anaesthesia was assessed verifying that the pupils were constricted and that blood pressure was stable (between 90 and 120 mmHg) and not affected by noxious stimulation of the skin. When necessary, a solution of etilefrin hydrochloride (Effortil, Boehringer-Ingelheim; antihypotensive) diluted with isotonic saline (1:10) was infused (0.2 mg/kg, i.v.) to maintain the blood pressure within this range. The tem-perature of the animals was kept between 37 and 388C by means of radiant heat.
Stimulation, recording and drugs: Successive monosynaptic re¯exes were produced by 1.2 xT stimulation at a constant frequency (single pulses 0.4sHz) of group Ia afferents of the PBSt or GS nerves. Monosynaptic re¯exes were recorded from the central ends of the sectioned L6 or L7 ventral roots. Evoked afferent volleys were recorded at lumbar segments L6±L7 by means of a silver ball electrode placed on the cord dorsum against an indifferent electrode inserted in the back muscles (Fig. 1a) . The indifferent electrode was placed on the paravertebral muscles. Low noise, high gain differential ampli®ers (Grass model P511, bandpass ®lters 0.3 Hz±10 kHz) were used to amplify the potentials. Stability of the preparation was essential for this study since it required 2±3 h of continuous observation of monosynaptic re¯exes evoked every 2.5 s. Therefore we used only animals where the amplitude of monosynaptic re¯exes remained relatively stable, with a variation by about 10% of the mean amplitude of successive monosynaptic re¯exes.
After recording for 1 h a series of control monosynaptic re¯ex responses SIN-1 (500 ìg/kg; Sigma-Aldrich) was dissolved in physiological saline (vehicle, 1 ml/kg) or arti®cial cerebrospinal¯uid (ACSF: 124 mM/l NaCl, 2 mM/l KCl, 2 mM/l MgCl 2 , 1.25 mM/l KH 2 PO 4 , 26 mM/l NaHCO 3 , 2 mM/l CaCl 2 , 11 mM/l glucose, pH 7.4) and slowly administered i.v. for 1 min.
In other series of experiments, we recorded the monosynaptic re¯exes before and after microinjection of the NO donor into the ventral horn. Microinjections of ACSF or physiological saline (1 ìl; control solution), or SIN-1 (dissolved in ACSF or physiological saline, 1 ìl; 10 À12 ±10 À3 M) were made using glass micropipettes (tip diameter, 20± 70 ìm). Solution of SIN-1 was prepared the same day of the experiment and strictly protected from light.
Monosynaptic re¯exes were recorded before and after microinjection of ACSF or physiological saline into the ventral horn. At the end of this control protocol, the micropipette was withdrawn and replaced with a micropipette containing SIN-1 that was reinserted close enough to the original position. The microelectrode holder (piezoelectric Burleigh, 6000 ULN) allowed changing micropipettes.
The present results were derived from those experiments in which blood pressure was reasonably steady (with blood pressure changes of , 20 mmHg).
Micropipette placement in the ventral horn was veri®ed histologically. The micropipette was cut and left in place. The animal was then killed with an overdose of pentobarbital and perfused with 10% formalin. The spinal cord was 
GS

RESULTS
Effect of systemic application of nitric oxide donor on the amplitude of monosynaptic re¯exes: It was observed that no statistically signi®cant changes in amplitude of monosynaptic re¯exes were produced 1 h after i.v. application of isotonic saline or ACSF (used as vehicle).
The effects of i.v. administration of SIN-1 (500 ìg/kg) on the amplitude of monosynaptic re¯exes, produced either by stimulation (1.2xT) of PBSt or GS nerves, were examined (n 5). Figure 1b±c shows the results obtained in one of them. Figure 1b shows the mean GS afferent volley and the monosynaptic re¯exes taken during control conditions, 20 min after vehicle administration, 20 min after administration of SIN-1, and recovery, respectively. As illustrated in Fig. 1b , no signi®cant changes in amplitude of afferent volleys were produced. However, note the great facilitatory effect, namely potentiation (about 1000% respect to control) after i.v. injection of the NO donor. This potentiation is similar to that described for post-tetanic facilitation in monosynaptic re¯ex responses [13] . Figure 1c shows the time course of the effect of SIN-1 on mean arterial blood pressure (BP), as well as the time course of amplitude of successive monosynaptic re¯exes in control conditions and after i.v. administration of SIN-1 (see arrow). After administration of SIN-1, a signi®cant decrease in the mean BP was observed. The onset of action occurred within the ®rst 5 min of administration, and BP did not change over the 60 min period of the experiment. Figure 1c also illustrates that potentiation of the monosynaptic re¯exes was already produced within 0.5±1 min after SIN-1 administration, and reached its maximal peak within 5±20 min. Note the recovery in the amplitude of the monosynaptic re¯exes 45 min after SIN-1 application. Similar responses were observed in four additional experiments, obtaining a statistically signi®cant maximal potentiation with respect to control of 704 AE 266% ( p , 0.01; Student's t-test). Figure 1d shows data of maximal potentiation in MSRs evoked by stimulation of PBSt (¯exor) or GS (extensor) nerves, as indicated. Note that stimulation of PBSt or GS nerves did not produce observable differences in the maximal potentiation between exors and extensors. Because it is well known that NO donors cause vascular effects, we examined whether there is a possible correlation between the fall in BP generated by SIN-1 and the increase in size of re¯ex. Decrease in BP and the maximal increase in MSR were taken from raw data of successive values during the time interval (5 min) of the maximal change in MSR amplitude after SIN-1. An example of such time interval for one experiment is illustrated as a horizontal bar in Fig. 1c . Figure 1d shows data obtained from ®ve different experiments where we illustrate that no correlation was found between the decrease in BP after SIN-1 and the maximal increase in amplitude of the monosynaptic re¯exes (expressed as a percentage change relative to control).
Effect of local application of nitric oxide donor on the amplitude of monosynaptic re¯exes: In other series of experiments (n 15) we recorded the monosynaptic reexes before and after microinjections of vehicle (ACSF or physiological saline), or NO donor into the ventral horn. It was observed that no statistically signi®cant changes in amplitude of monosynaptic re¯exes were produced 1 h after microinjections of isotonic saline or ACSF (used as vehicle). Figure 2b shows the time course of the effect of SIN-1 on mean arterial BP, as well as the amplitude graph for successive monosynaptic re¯exes in control conditions and after local application of SIN-1 (see arrow). It can be seen that no changes in mean BP were produced, however the potentiation of monosynaptic re¯exes was already produced 1 min after local application of SIN-1, and reached its maximal peak within 10±20 min. Note that recovery of re¯exes was produced within 45±50 min after such local application of SIN-1. Figure 2b also shows histological reconstruction of the micropipette track, con®rming that SIN-1 was applied into the ventral horn in the same lumbar segment where monosynaptic re¯exes were recorded.
To obtain a more complete characterization of the effects of SIN-1 on the potentiation of monosynaptic re¯exes (evoked by stimulation of PBSt or GS), we examined the effects of four concentrations of SIN-1 (10 À12 , 10 À9 , 10 À5 , and 10 À3 M). Only one microinjection of SIN-1 was made per animal. It was found that application of such concentrations of SIN-1 can produce a statistically signi®cant increase in the amplitude of the monosynaptic re¯exes with a mean potentiation respect to control of 355 AE 160% ( p , 0.01; Student's t-test). The maximal increase in MSR was taken from raw data of successive values during the time interval (5 min) of the maximal change in MSR amplitude after SIN-1. An example of such time interval for one experiment is illustrated as a horizontal bar in Fig.  2b . Figure 2c shows a dose-dependent increase in the monosynaptic re¯ex amplitude after SIN-1 local application. As suggested in Fig. 1d no statistically signi®cant difference was found between maximal potentiation of PBSt or GS monosynaptic re¯exes after local administration of SIN-1.
DISCUSSION
Site of action of NO: Since NO can diffuse within the spinal cord gray matter after intravenous administration of SIN-1, it could act at many possible sites. For this reason our main interest was to explore the effects of SIN-1 after the local application of SIN-1 into the ventral horn, where NOS containing motoneurons are localized [4±7].
The extreme diffusibility of NO allows a rapid threedimensional spread of the gas irrespective of the presence of membranes. The important question arises as to how far NO travels. According to Garthwaite and Boulton [14] , NO generated at a single point source should be able to in¯u-ence target cells within a sphere with a diameter of $0.3 mm. Therefore, if we assume that the diameter of the L6 lumbar cat spinal cord is $5 mm with a longitudinal extension of 1 cm, then the NO generated from motoneurones after SIN-1 microinjection into the ventral horn should be able to in¯uence only neurones within the ventral horn of the same segment. This led to the suggestion that the site of action of NO after microinjection of SIN-1 into the ventral horn is limited to the same ventral horn.
Synaptic plasticity of the monosynaptic re¯ex pathway: Lloyd described that tetanic nerve stimulation can produce a potentiation in the monosynaptic re¯ex of the cat spinal cord [13] , thus showing that synaptic plastic changes can occur in neurons of the CNS [15] . The extent to which nitric oxide contributes to this potentiation has not been yet established.
Because NOS-containing motoneurones are located in the ventral horn and because microinjection of SIN-1 into the ventral horn can produce a potentiation of monosynaptic re¯exes without affecting the afferent volleys, we propose the possibility that NO acts as a retrograde messenger released from the motoneurons, and diffuses back across the synapse to increase neurotransmitter release from Ia afferents. Therefore, this enhancement in the synaptic ef®cacy could explain the great increase in the amplitude of monosynaptic re¯exes after the NO donor was locally applied. However, further work is necessary to disclose the identity of the target neurons in¯uenced by NO in the ventral horn, as well as the associated changes in the concentration of NO generated.
Functional implications: The amplitude of the H-re¯ex in the human is task-dependent because is greater during standing than during walking [16] . In this context, the physiological mechanisms during a motor task, by which release of NO could be enhanced or inhibited, remains to be determined. However, our data suggest that NO plays a role in the modulation of amplitude of the monosynaptic re¯exes.
NO is a gas that can readily cross the cellular membranes by simple diffusion, allowing NO released from a neuron to spread in three dimensions and to act on neighboring target cells. It is very tempting to propose that in physiological conditions the diffusion of nitric oxide would provide a synergic potentiation of monosynaptic re¯exes.
We propose that in the Ia-motoneuron path, transmitter release from Ia afferent endings could be enhanced by retrograde release of NO from motoneurons. In this context, a relevant question would be the extent to which this retrograde mechanism is activated during execution of operantly conditioned motor tasks in intact, non-anaesthetised behaving animals. Based on the observations of Wolpaw [17] , one may anticipate that levels of NO would be increased in the ventral horn after potentiation of the Hre¯ex by operant conditioning. This proposal suggests that during motor tasks the spinal cord involves NO release that plays a role in the potentiation of monosynaptic re¯exes. Until these questions are answered discussion of the physiological role of nitric oxide in motor function, although exciting, would be highly speculative.
CONCLUSION
Monosynaptic re¯exes of the cat spinal cord can be potentiated by nitric oxide.
